MSB Financial Corp. (NASDAQ:MSBF)

intratio ranking Try 7 days free
About the company

MSB Financial Corp. is a bank holding company, which engages in the provision of traditional deposits and lending services through the Bank. It operates through the following segments: Residential Mortgage, Commercial Real Estate, Construction, Commercial and Industrial, and Consumer. The Residential Mortgage segment offers four-family loans, which are first liens, and home equity loans, which consist of first and second liens. The Commercial Real Estate segment consists of owner and non-owner occupied loans and is further disaggregated into owner-occupied loans and investor properties, which have medium risk due to historical activity on these type loans. The Construction segment offers one-to four-family owner occupied, which includes land loans. The Commercial and Industrial segment covers loans made for the purpose of financing the activities of commercial customers. The Consumer segment includes installment loans and overdraft lines of credit connected with customer deposit accounts. The company was founded in 1911 and is headquartered in Millington, NJ.

Sector

Finance

Industry

Savings Banks

Employees

None

$19.00M

Total Revenue

None

Employees

$51.90M

Market Capitalization

12.81

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$M

Net Margin (in %)

Total net margin

$4M

Dividend Yield (in %)

Dividend per share

$0.11

90-days Stock Price Forecast (in %)

PREDICT MONTHLY

$49 / Month

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed monthly

OPTIMIZE YEARLY

$999 / Year

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed yearly

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
MB Financial, Inc. MBFI 3602.30 979.00 1.26 16.62 22.17
IBERIABANK Corp. IBKC 2283.24 1201.00 0.55 7.44 25.39
First Defiance Financial Corp. FDEF 362.40 160.00 0.74 7.31 30.79
BSB Bancorp, Inc. (Massachusetts) BLMT 361.24 3.00 11.56 142.78 74.58
BBX Capital Corp. BBX 254.41 782.00 0.53 -6.66 -4.64
MSB Financial Corp. MSBF 51.90 19.00 0.81 12.81 22.03
Bancorp 34, Inc. BCTF 28.74 16.00 0.67 16.52 11.18
Ottawa Bancorp, Inc. OTTW 28.65 11.00 0.61 18.37 14.59

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Mesoblast Corporate Update and Financial Results Webcast

11d ago, source: Nasdaq

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast today to provide a corporate update, and report financial and operational highlights ...

Treasury Stance On Ransomware Payment Could Hurt Targets

13d ago, source: Law360

Recent statements from two U.S. Department of the Treasury offices indicate that paying off ransomware with cryptocurrency may trigger certain registration requirements and U.S. sanctions scrutiny, ...

Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L

11d ago, source: Nasdaq

Mesoblast Limited, today announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblast ...

NetCents Technology Provides Update on NetCents Cryptocurrency Visa Card

13d ago, source: Stockhouse

To complete this process NetCents has provided the bank with the following for consideration: Expert legal opinion to certify NetCents compliance with all relevant AML laws and Fintrac MSB ...

Mesoblast Corporate Update and Financial Results Webcast

10d ago, source: MarketWatch

MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast today to provide a corporate update, and report financial and operational highlights for the ...

Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L

11d ago, source: wallstreet online

Mesoblast Limited (Nasdaq:MESO; ASX:MSB) is a world leader in developing allogeneic (off-the-shelf) cellular medicines. The Company has ... events or our future financial performance and involve ...

Mesoblast Corporate Update and Financial Results Webcast

10d ago, source: Benzinga.com

Mesoblast Limited (NASDAQ:MESO, ASX:MSB)) is a world leader in developing allogeneic (off-the-shelf) cellular medicines. The Company has leveraged its proprietary mesenchymal lineage cell therapy ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.